Active Stocks
Thu Nov 21 2024 15:58:46
  1. Tata Steel share price
  2. 140.25 0.57%
  1. Tata Motors share price
  2. 773.70 -1.24%
  1. State Bank Of India share price
  2. 780.85 -2.64%
  1. NTPC share price
  2. 356.10 -2.73%
  1. Power Grid Corporation Of India share price
  2. 325.80 3.41%
Business News/Market/Market Stats/    Alembic Pharmaceuticals

ALEMBIC PHARMACEUTICALS SUMMARY

Alembic Pharmaceuticals is trading 0.40% lower at Rs 1038.40 as compared to its last closing price. Alembic Pharmaceuticals has been trading in the price range of 1042.25 & 1020.85. Alembic Pharmaceuticals has given 37% in this year & 0.8% in the last 5 days.

 

Alembic Pharmaceuticals has TTM P/E ratio 36.66 as compared to the sector P/E of 31.15. There are 9 analysts who have initiated coverage on Alembic Pharmaceuticals. There are 3 analysts who have given it a strong buy rating & 0 analysts have given it a buy rating. 1 analysts have given the stock a sell rating.

 

The company posted a net profit of 153.4 Crores in its last quarter.

 

Listed peers of Alembic Pharmaceuticals include JB Chemicals & Pharmaceuticals (2.95%), Natco Pharma (0.75%), Alembic Pharmaceuticals (-0.4%) etc.

 

Alembic Pharmaceuticals has a 69.61% promoter holding & 30.39% public holding.

FAQs about Alembic Pharmaceuticals

Alembic Pharmaceuticals is trading at 1038.40 as on 21 Nov, 2024 3:29:56 PM. This is -0.40% lower as compared to its previous closing price of 1042.6
The market capitalization of Alembic Pharmaceuticals is 20449.45 Cr as on 21 Nov, 2024 3:29:56 PM.
The average broker rating on Alembic Pharmaceuticals is Buy. The breakup of analyst rating is given below -
  • 0 analysts have given a strong sell rating
  • 1 analysts have given a sell rating
  • 5 analysts have given a hold rating
  • 0 analysts have given a buy rating
  • 3 analysts have given a strong buy rating
The 52 wk high for Alembic Pharmaceuticals is 1296.15 whereas the 52 wk low is 710.5
Alembic Pharmaceuticals can be analyzed on the following key metrics -
  • TTM P/E: 36.66
  • Sector P/E: 31.15
  • Dividend Yield: 1.06%
  • D/E ratio: -
Alembic Pharmaceuticals reported a net profit of 615.82 Cr in 2024.
Recommended For You